Hall MC - Search Results

1

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.

Clark PE, Hall MC, Borden LS Jr, Miller AA, Hu JJ, Lee WR, Stindt D, D'Agostino R Jr, Lovato J, Harmon M, Torti FM. Clark PE, et al. Among authors: hall mc. Urology. 2006 Jun;67(6):1257-61. doi: 10.1016/j.urology.2005.12.035. Urology. 2006. PMID: 16765186 Clinical Trial.

2

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM. Clark PE, et al. Among authors: hall mc. Urology. 2004 Jun;63(6):1061-5. doi: 10.1016/j.urology.2004.01.035. Urology. 2004. PMID: 15183950 Clinical Trial.

3

Utility of frozen section analysis of resection margins during partial nephrectomy.

Kubinski DJ, Clark PE, Assimos DG, Hall MC. Kubinski DJ, et al. Among authors: hall mc. Urology. 2004 Jul;64(1):31-4. doi: 10.1016/j.urology.2004.03.011. Urology. 2004. PMID: 15245928 Review.

4

Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.

Schwartz GG, Hall MC, Stindt D, Patton S, Lovato J, Torti FM. Schwartz GG, et al. Among authors: hall mc. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680-5. doi: 10.1158/1078-0432.CCR-05-1237. Clin Cancer Res. 2005. PMID: 16361554 Clinical Trial.

5

Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.

Borden LS Jr, Clark PE, Lovato J, Hall MC, Stindt D, Harmon M, M Mohler R, Torti FM. Borden LS Jr, et al. Among authors: hall mc. Cancer. 2006 Sep 1;107(5):1093-100. doi: 10.1002/cncr.22078. Cancer. 2006. PMID: 16888761 Free article. Clinical Trial.

6

Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?

Phillips JJ, Hall MC, Lee WR, Clark PE. Phillips JJ, et al. Among authors: hall mc. Urol Oncol. 2007 May-Jun;25(3):196-200. doi: 10.1016/j.urolonc.2006.06.004. Urol Oncol. 2007. PMID: 17483015

7

Randomized prospective trial of a novel local anesthetic technique for extensive prostate biopsy.

Matlaga BR, Lovato JF, Hall MC. Matlaga BR, et al. Among authors: hall mc. Urology. 2003 May;61(5):972-6. doi: 10.1016/s0090-4295(03)00003-7. Urology. 2003. PMID: 12736018 Clinical Trial.

8

Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone.

Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Matlaga BR, et al. Among authors: hall mc. J Urol. 2002 Dec;168(6):2401-5. doi: 10.1016/S0022-5347(05)64154-7. J Urol. 2002. PMID: 12441926 Clinical Trial.

9

Response of hormone refractory prostate cancer to lycopene.

Matlaga BR, Hall MC, Stindt D, Torti FM. Matlaga BR, et al. Among authors: hall mc. J Urol. 2001 Aug;166(2):613. J Urol. 2001. PMID: 11458084 No abstract available.

10

Bladder cancer.

Borden LS Jr, Clark PE, Hall MC. Borden LS Jr, et al. Among authors: hall mc. Curr Opin Oncol. 2003 May;15(3):227-33. doi: 10.1097/00001622-200305000-00009. Curr Opin Oncol. 2003. PMID: 12778017 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters